Video recordings and presentations from the conference are available here.
Day 1: March 8, 2010
8:00 - 9:00 / Check in and Continental Breakfast
9:00 - 9:20 / Welcome and Introduction
• Dean Paul Schiff Berman, Sandra Day O'Connor College of Law
9:20 - 10:15 / Keynote Address: The Promise and Progress of Personalized Medicine
• Lee Hartwell, President and Director, Fred Hutchinson Cancer Research Center, Seattle; Incoming Co-Director, Center for Sustainable Health, The Biodesign Institute, Arizona State University
10:15 - 10:30 / Break
10:30 - 12:15 / Session I: Case Studies and Examples: Personalized Medicine in the Clinic
Presentation of four real-life examples of Personalized Medicine being applied to patient care, and the resulting opportunities and challenges.
• Moderator: Deborah Runkle, Senior Program Associate, American Association for the Advancement of Science
• Derek Abbott, Assistant Professor, Department of Pathology, Case Western Reserve University, Cleveland
• Prasad Devarajan, Williams Endowed Chair, Professor of Pediatrics and Developmental Biology, Director of Nephrology and Hypertension, Director of Clinical Laboratories, and CEO of the Dialysis Unit at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati
• Donald E. McAlpine, Assistant Professor of Psychiatry, Mayo Clinic Minnesota
• Glen Weiss, Co-head, Lung Cancer Unit, Translational Genomics Research Institute, and Director, Thoracic Oncology, TGen Clinical Research Services, Scottsdale Healthcare
12:15 - 1:30 / Lunch Speaker:
• David Ewing Duncan, Author, Experimental man: what one man's body reveals about his future, your health, and our toxic world
1:30 - 3:15 / Session II: Health Care Professionals and Personalized Medicine
Roundtable about training and education, professional responsibility and liability concerns and how providers can effectively use this new knowledge.
• Moderator: James G. Hodge Jr., Lincoln Professor of Health Law and Ethics, and Director, Public Health Law and Policy Program, Sandra Day O’Connor College of Law, Arizona State University
• Michael Birt, Co-Director, The Biodesign Institute, Center for Sustainable Health, Arizona State University; Professor, W.P. Carey School of Business, ASU; Executive Director, Pacific Health Summit; Affiliate Investigator, Fred Hutchinson Cancer Research Center, Seattle
• James P. Evans, Director, Adult/Cancer Genetics Services and The Bryson Program in Human Genetics, The University of North Carolina at Chapel Hill; Editor-in-Chief, Genetics in Medicine, the American College of Medical Genetics
• Amalia Issa, Founding Director of the Program in Personalized Medicine and Targeted Therapeutics, and Associate Professor of
Pharmacological Sciences and of Pharmacy Administration and Public Health, College of Pharmacy, University of Houston; Investigator, The Methodist Hospital Research Institute, Houston
• Gary E. Marchant, Professor of Law and Executive Director, Center for Law, Science & Innovation, Sandra Day O'Connor College of Law; Lincoln Professor of Emerging Technologies, Law and Ethics; Professor, School of Life Sciences, Arizona State University
• Robert Milligan, Attorney, Milligan Lawless Taylor Murphy & Bailey, P.C., Phoenix
3:15 - 3:30 / Break
3:30 - 5:15 / Session III: Managing Mountains of Information: The Nexus of Personalized Medicine and Information Technology
Panel discussion involving a physician, health administrator, private health insurance company executive, electronic health records expert, patient advocate, privacy expert and scientific researcher.
• Moderator: Gary E. Marchant, Executive Director, Center for Law, Science & Innovation, Sandra Day O’Connor College of Law, Arizona State University
• Michael Christman, President and CEO, Coriell Institute for Medical Research
• Maren T. Scheuner,
Senior Research Scientist, Center for Health Policy Research, University of California, Los Angeles; Adjunct Associate Professor, UCLA School of Public Health
• Peter J. Tonellato, Senior Research Scientist and Director, Laboratory for Personalized Medicine (LPM), Center for Biomedical Informatics, Harvard Medical School; Visiting Professor, Department of Pathology, Beth Israel Deaconess Medical Center
• Paul Wicks, Research and Development Director, PatientsLikeMe
Day 2: March 9, 2010
8:00 - 8:30 / Continental Breakfast
8:30 - 10:15 / Session IV: Ethical and Policy Issues
Presentation about informed consent, privacy and confidentiality, access/equity, and race and Personalized Medicine.
• Moderator: Katherine Hunt, Assistant Professor of Medicine, and Genetic Counseling Program Coordinator, Mayo Clinic Arizona
• Patricia Deverka, Research Associate Professor, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
• Henry Greely, Deane F. and Kate Edelman Johnson Professor of Law, Stanford Law School; Professor (by courtesy) of Genetics, Stanford School of Medicine
• Kenneth Offit, Chief, Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York City
• Harald Schmidt, Assistant Director, Nuffield Council on Bioethics, London
10:15 - 10:30 / Break
10:30 - 12:15 / Session V: What's Holding Personalized Medicine Back and How Can We Increase the Pace Forward?
Panel discussion about scientific validation, economics of Personalized Medicine products, regulatory requirements, reimbursement and intellectual property.
• Moderator: John J. Sninsky, Vice President, Discovery Research, Celera
• Robert Cook-Deegan, Director, Center for Genome Ethics, Law, and Policy, Institute for Genome Sciences and Policy, Duke University; Research Professor, Public Policy Studies, Biology and Department of Medicine, Duke University
• Barbara J. Evans, Associate Professor of Law; Co-director, Health Law and Policy Institute; Director, Center on Biotechnology & Law, University of Houston Law Center
• Scott D. Ramsey, Member, Cancer Prevention Research Program, and Director, Cancer Technology Assessment Group, Fred Hutchinson Cancer Research Center, Seattle; Professor, School of Medicine, School of Pharmacy, and the Institute for Public Health Genetics, University of Washington; Director, Cancer Prevention and Survivorship Program, Seattle Cancer Care Alliance
• Marc S. Williams,
Director, Intermountain Healthcare Clinical Genetics Institute, Salt Lake City; Clinical Professor of Pediatrics, Division of Medical Genetics, and Adjunct Professor of Biomedical Informatics, University of Utah
12:15 - 1:30 / Lunch Speaker
• Denis A. Cortese, Emeritus President and Chief Executive Officer, Mayo Clinic
1:30 - 3:15 / Session VI: Personalized Medicine and the Patient of the 21st Century
Panel discussion on the public knowledge and concerns about genetics, how patients respond to genetic risk information, and integrating environmental and lifestyle factors with genetics.
Moderator: Andrew Askland, Director, Center for Law, Science & Innovation, Sandra Day O’Connor College of Law, Arizona State University
• Lee Gutkind, Professor, Consortium for Science, Policy & Outcomes, and the Hugh Downs School of Human Communication, Arizona State University; Founding Editor, Creative Nonfiction
• Katherine Hunt, Assistant Professor of Medicine, and Genetic Counseling Program Coordinator, Mayo Clinic Arizona
• Pagan Kennedy, Co-author, Personalizing Medicine
• Michael J. Saks, Regents' Professor of Law and Psychology, and Faculty Fellow, Center for Law, Science & Innovaion, Sandra Day O'Connor College of Law, Arizona State University
• Otis Webb Brawley, Chief Medical Officer and Executive Vice President, American Cancer Society
3:15 - 4:30 / Session VII: What's in Store for Personalized Medicine? The Future is Never What We Expect it to Be
A fitting end to the three-colloqium series, this presentation offers futurists outlining possible scenarios to come.
• Moderator: Mark S. Frankel, Director, Scientific Freedom, Responsibility and Law Program, American Association for the Advancement of Science
• James Canton, Founder, CEO and Chairman, Institute for Global Futures, San Francisco; Senior Fellow, Center for Research in Innovation, Kellogg School of Management, Northwestern University, Chicago
• George Poste, Chief Scientist, Complex Adaptive Systems Initiative (CASI); Regents’ Professor and Del E. Webb Chair in Health Innovation, Arizona State University